INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $221,955 | -98.5% | 4,261 | -98.1% | 0.00% | -97.8% |
| Q2 2023 | $14,534,220 | +4112.8% | 229,536 | +2155.0% | 0.04% | +2150.0% |
| Q1 2021 | $345,000 | -13.8% | 10,179 | -60.8% | 0.00% | -33.3% |
| Q1 2020 | $400,000 | -84.3% | 26,000 | -86.8% | 0.00% | -66.7% |
| Q2 2019 | $2,555,000 | -13.7% | 196,803 | -19.0% | 0.01% | -18.2% |
| Q1 2019 | $2,960,000 | +30.1% | 243,003 | +21.6% | 0.01% | +10.0% |
| Q4 2018 | $2,276,000 | -65.3% | 199,803 | -33.9% | 0.01% | -58.3% |
| Q3 2018 | $6,561,000 | +12.8% | 302,348 | -8.1% | 0.02% | 0.0% |
| Q2 2018 | $5,814,000 | +27.4% | 329,048 | +51.8% | 0.02% | +14.3% |
| Q1 2018 | $4,563,000 | – | 216,759 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |